Flu Vaccines are ineffective and dangerous.
- classicrecords1
- Dec 9, 2025
- 3 min read
Updated: Aug 26
1) “You need a DB RCT (Double Blind Random Control Trial) to see the benefits.
There is a reason they don’t do the DB RCTs to prove the vaccine works. Can you guess what it is? Could it be because they don’t want to expose the fact that the vaccines don’t work.
Of course, today they can argue that they are not allowed to test whether the vaccine works or not because they can’t have a true placebo group because it would not be the standard of care.
Convenient, isn’t it?
So based on the rules, we’ll never be able to use a DB RCT to determine whether the vaccine works or not. They like it that way. No complaints from the drug companies on that one!
The best piece of advice I can offer is always demand to see the all-cause risk benefit data before you consent to getting a vaccine, any vaccine.”
2) “randomised (real) placebo-controlled trials give you a good idea of the incidence of influenza (in the older trials, by a rise in antibody titres and or a viral positive culture isolate). When you pool the data together, you are not looking at one trial or dataset; you are looking at several data sets observed and recorded at the height of the “winter crisis” season. In the healthy adult's review, the placebo arm picked up 465 cases out of 18,593 participants. So, of the folks with symptoms, 97.5% were not caused by influenza. No trials were able to detect deaths, hospitalisations were relatively rare. The trials spanned 50 years of data, so we had all the highs, the lows and the maybes and even 2 influenza pandemics.
So influenza is rare, loads more agents causing the same signs and symptoms are lumped under the appalling term “flu”, and population interventions such as inactivated vaccines do not stand a chance against a relatively rare moving target like influenza.”
3) ‘Profound Breach of Trust’: Pfizer Omitted Trial Data Showing Higher Mortality, Kidney Failure in Seniors Given mRNA Flu Shot.
4) STUDY: Common Vaccines Linked to 38-50% Increased Risk of Dementia and Alzheimer’s
The single largest vaccine–dementia study ever conducted (n=13.3 million) finds risk intensifies with more doses, remains elevated for a full decade, and is strongest after flu and pneumococcal shots.
5) Administration of inactivated influenza vaccine can induce an acute and transient lymphocytopenia, as can Comirnaty. So, after vaccination, you are very vulnerable, and no one should be vaccinated when there is an epidemic.
6) People who received a flu vaccine formulated for the 2024-2025 flu season had a 27% higher risk of getting the flu than those who didn’t get the vaccine, suggesting “the vaccine has not been effective in preventing influenza this season,” according to a new preprint study.
7) The FDA proposed this wording for the vaccine labels:
“In two separate postmarketing observational studies, an increased risk of febrile seizures was observed during the first day following vaccination with standard dose trivalent (2024-2025) and quadrivalent (2023-2024) influenza vaccines in children 6 months through 4 years of age.”
The warning would be added to the labels of AstraZeneca’s FluMist, GSK’s Fluarix, ID Biomedical’s FluLaval, Sanofi Pasteur’s Fluzone, and Sequiris’ Afluria and Flucelvax vaccines.
8) According to the FDA briefing document, severe systemic reactions were 4× MORE COMMON with the mRNA flu shot than with the traditional flu shot.
9) BREAKING: FDA Data Reanalysis Sent to Secretary Kennedy Finds Moderna’s mRNA Flu Shot Approval Should Be Immediately Withdrawn.
We directly reanalyzed the FDA’s own data used to approve mFLUSIVA and found an extreme risk-benefit profile that is impossible to justify.
10) An influenza drug prescribed to 25 million Americans since 2014 roughly doubles the risk of death in hospitalized patients who receive it, researchers have found.
About 20 percent of patients given the medicine, oseltamivir — sold both as a generic and under the name Tamiflu — died over the next 90 days, the researchers reported. Oseltamivir proved so deadly the researchers stopped its use in the trial early.
“Treatment with oseltamivir is ineffective and highly likely to increase 90-day mortality in critically ill patients with influenza,” they wrote bluntly in a 29-page “preprint” released in late July.
The stunning finding suggests Tamiflu has likely killed tens of thousands of older Americans, and very possibly more than 100,000, since the Swiss drugmaker Roche introduced it 27 years ago. Yet legacy media health reporters have entirely ignored the study.
Comments